Gemtuzumab (Anti-Siglec-3 / CD33)
Gemtuzumab (Anti-Siglec-3 / CD33) a monoclonal antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). It can be used for the research of acute myeloid leukemia.MW :145.22 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A3161 |
| Sku # | A3161-1mg*25 |
| Pricing | 1mg*25, $5070.00 |